Toggle navigation
Home
Search
Services
Blog
Contact
About
Apoptosis Inhibitors - Therapy for Neurotoxicity
Pulliam, Lynn
Neurex Corporation, Menlo Park, CA, United States
Search 44 grants from Lynn Pulliam
Search grants from Neurex Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Tumor Necrosis Factor Modulation of CPCs
Principles of Behavior Change: Choice and Context
Ovarian Cancer National Alliance's 9th Annual Conference
Regulation of Renal H+ATPase by Glycolysis
Single Cell Marking Studies of the Auditory Nerve
Recently added grants:
Molecular Mechanisms of 20-HETE-mediated Vascular Dysfunction and Hypertension
Mechanisms of Immune Activation in Hypertension
Population-level interventions and community environment effects on child obesity disparities
Deconvoluting the Vascular Adhesome
Flow responsive endothelial Pnpt1: an exoribonuclease that regulates mitochondrial function and vascular disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41MH056311-01
Application #
2256468
Study Section
Small Business Research Review Committee (MHSB)
Project Start
1996-08-01
Project End
1997-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Neurex Corporation
Department
Type
DUNS #
City
Menlo Park
State
CA
Country
United States
Zip Code
94025
Publications
Pulliam, L; Zhou, M; Stubblebine, M et al.
(1998)
Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor.
J Neurosci Res 54:530-8
Comments
Be the first to comment on Lynn Pulliam's grant